Published in Antimicrob Agents Chemother on April 13, 2009
Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87
Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections. Antimicrob Agents Chemother (2011) 0.96
Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis. Antimicrob Agents Chemother (2010) 0.85
Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. Antimicrob Agents Chemother (2012) 0.83
Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother (1974) 5.19
Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis (1998) 3.76
Treatment of bacterial meningitis. N Engl J Med (1997) 3.07
Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med (1998) 2.91
Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1995) 2.50
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis (2001) 2.39
Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother (1994) 1.96
Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin Infect Dis (2001) 1.74
Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother (2006) 1.34
Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis. Antimicrob Agents Chemother (2007) 1.25
Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother (2004) 1.23
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn Microbiol Infect Dis (2006) 1.18
Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall. Antimicrob Agents Chemother (2007) 0.96
Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. J Antimicrob Chemother (2002) 0.90
Daptomycin: a new treatment for insidious infections due to gram-positive pathogens. Swiss Med Wkly (2008) 0.84
Studies on the transfer of subviral infectivity from SV40-induced hamster tumor cells to indicator cells. Virology (1966) 4.16
Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes). Proc Natl Acad Sci U S A (1972) 3.89
Influence of environmental conditions on biofilm formation by Hafnia alvei strains. Vet Microbiol (2007) 2.77
To resuscitate or not, that is the question. Med J Aust (1989) 1.93
Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1967) 1.91
Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus. Nature (1971) 1.91
Selective transformation of B lymphocytes by E.B. virus. Lancet (1973) 1.84
A new tumour-derived transforming strain of Epstein-Barr virus. Nature (1978) 1.84
Dilution and redistribution effects of rapid 2-litre infusions of 0.9% (w/v) saline and 5% (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: a double-blind crossover study. Clin Sci (Lond) (2001) 1.82
Studies on leukocytes growing in continuous culture derived from normal human donors. J Natl Cancer Inst (1968) 1.80
B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus. J Natl Cancer Inst (1974) 1.75
Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet (1972) 1.71
How far should we investigate and treat prostate cancer? A lawyer's perspective. Med J Aust (1994) 1.71
Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg (2000) 1.65
Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA. J Virol (1981) 1.54
Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg (2010) 1.46
Scleral implants: an historical perspective. Surv Ophthalmol (1991) 1.39
Blood ammonia levels as early indicator of allograft viability in human orthotopic liver transplantation. Am J Gastroenterol (1994) 1.38
Confidentiality and the AMA's new code of ethics. Med J Aust (1997) 1.38
ESPEN Guidelines on Enteral Nutrition: Geriatrics. Clin Nutr (2006) 1.37
Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures. Proc Soc Exp Biol Med (1970) 1.37
Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus. J Virol (1976) 1.37
Risk factors of acute renal failure after liver transplantation. Kidney Int (2006) 1.36
Infectious mononucleosis: complement-fixing antibodies to herpes-like virus associated with Burkitt lymphoma. Science (1968) 1.30
Biologic and antigenic characteristics of Epstein-Barr virus-related Herpesviruses of chimpanzees and baboons. Int J Cancer (1977) 1.29
False positive results for leucocytes in urine dipstick test with common antibiotics. BMJ (1996) 1.29
Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine. Proc Soc Exp Biol Med (1972) 1.26
In vitro stimulation of human lymphocytes by Epstein-Barr virus. Cell Immunol (1972) 1.26
DNA of herpesvirus pan, a third member of the Epstein-Barr virus-Herpesvirus papio group. J Virol (1982) 1.24
Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol (2001) 1.20
Immunoferritin and immunofluorescent studies with Epstein-Barr virus and herpes simplex virus by use of human sera and hyperimmune rabbit sera. J Natl Cancer Inst (1970) 1.19
Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. J Antimicrob Chemother (2000) 1.16
Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model. J Antimicrob Chemother (2000) 1.16
Symptomatology of late-life minor depression among primary care patients. Psychosomatics (1990) 1.15
The treatment of hypoalbuminaemia. Clin Nutr (2001) 1.13
Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrob Agents Chemother (1999) 1.13
Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrob Agents Chemother (2000) 1.10
Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med (2008) 1.09
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation (2000) 1.07
Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain. Eur J Clin Microbiol Infect Dis (1999) 1.07
Comparative studies of Epstein-Barr virus strains from Ghana and the United States. Int J Cancer (1976) 1.07
Determination of the disulphide bonding pattern in proteins by local and global analysis of nuclear magnetic resonance data. Application to flavoridin. J Mol Biol (1993) 1.06
Association of EB-virus infection with the post-perfusion syndrome. Lancet (1969) 1.05
Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Antimicrob Agents Chemother (2003) 1.03
Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly (2002) 1.01
HL-A antigens of human lymphoid cells in long-term tissue culture. Transplantation (1969) 1.00
NIH clinical staff conference. Burkitt's tumor. Ann Intern Med (1969) 0.98
The incidence of complement-fixing antibodies to herpes simplex and herpes-like viruses in man and rhesus monkeys. Proc Soc Exp Biol Med (1968) 0.98
Practical handling of AIO admixtures - Guidelines on Parenteral Nutrition, Chapter 10. Ger Med Sci (2009) 0.97
Leukocyte transforming agent (Epstein-Barr virus) in newborn infants and older individuals. J Pediatr (1976) 0.96
Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall. Antimicrob Agents Chemother (2007) 0.96
Total substitution of fish oil by vegetable oils in gilthead sea bream (Sparus aurata) diets: effects on hepatic Mx expression and some immune parameters. Fish Shellfish Immunol (2007) 0.95
Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis. Eur J Clin Microbiol Infect Dis (2003) 0.95
Attempts to transmit infectious mononucleosis to rhesus monkeys and marmosets and to isolate herpes-like virus. Proc Soc Exp Biol Med (1969) 0.95
Patterns of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccines. Proc Soc Exp Biol Med (1967) 0.94
Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC Microbiol (2001) 0.94
Murine leukemia viruses: rupture with ether and detergents to subviral constituents. Natl Cancer Inst Monogr (1966) 0.93
[Humidifier lung]. Schweiz Med Wochenschr (1981) 0.92
Does the standard vs piggyback surgical technique affect the development of early acute renal failure after orthotopic liver transplantation? Transplant Proc (2003) 0.92
Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro. Antimicrob Agents Chemother (2003) 0.91
Relationship of Epstein-Barr virus-induced membrane antigens in lymphoid cells to viral envelope antigens. J Immunol (1970) 0.91
Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus. J Clin Microbiol (1982) 0.90
Results of the conversion to everolimus in renal transplant recipients with posttransplantation malignancies. Transplant Proc (2010) 0.90
Oncogenic herpesviruses of nonhuman primates. Comp Immunol Microbiol Infect Dis (1979) 0.89
Invasion and intracellular survival of Hafnia alvei strains in human epithelial cells. J Appl Microbiol (2008) 0.89
Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantation. Clin Biochem (1995) 0.89
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J Natl Cancer Inst (1980) 0.87
Eversion thromboendovenectomy for organized portal vein thrombosis encountered during liver transplantation. Transplant Proc (2003) 0.87
Retention of Teflon particles in hamster lungs: a stereological study. J Aerosol Med (2000) 0.87
Functional hypoglycemia in early latent diabetes. Ann N Y Acad Sci (1968) 0.87
First report of Streptococcus iniae in red porgy (Pagrus pagrus, L.). J Fish Dis (2010) 0.87
Prenatal cytogenetic diagnosis: some potential legal implications. Med J Aust (1985) 0.86
Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation. Leukemia (1999) 0.86
Hepatic artery complications after liver transplantation. Clin Transplant (1994) 0.86
Evaluation of ceftobiprole activity against a variety of gram-negative pathogens, including Escherichia coli, Haemophilus influenzae (β-lactamase positive and β-lactamase negative), and Klebsiella pneumoniae, in a rabbit meningitis model. Antimicrob Agents Chemother (2011) 0.86
Meeting the nutritional requirements of hospitalized patients: an interdisciplinary approach to hospital catering. Clin Nutr (2008) 0.86
Ventricular function during liver reperfusion in hepatic transplantation. A transesophageal echocardiographic study. Transplantation (1994) 0.86
Hepatic artery complications in a series of 300 orthotopic liver transplants. Transplant Proc (2000) 0.86
Epstein-Barr virus and human malignancy. Ann Intern Med (1977) 0.85
Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis. Arthritis Rheum (1985) 0.85
Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci. J Antimicrob Chemother (2004) 0.85
Oral excretion of E.B. virus. Lancet (1973) 0.85
Lymphoproliferative disorders in an IL-7 transgenic mouse line. Leukemia (1993) 0.85
Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro. J Antimicrob Chemother (2001) 0.84
[Body-packer & body-stuffer - a medical challenge]. Praxis (Bern 1994) (2010) 0.84